The Administrative Core

行政核心

基本信息

  • 批准号:
    10612949
  • 负责人:
  • 金额:
    $ 24.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-30 至 2027-03-31
  • 项目状态:
    未结题

项目摘要

SUMMARY The inception of the Columbia University Digestive and Disease Research Center (CU-DLDRC) in 2019 has its foundational roots over the past 15 years through the resounding growth of basic, translational and clinical research. The CU-DLDRC reflects the enthusiasm, collaborations, productivity and success of its members as well as the long-term institutional support of digestive disease research at Columbia University. The CU-DLDRC comprises an interactive group of 49 highly productive members (30 full and 19 associate), united by their strive for excellence in adult and pediatric digestive disease research and care. Since the CU-DLDRC’s inception, the Administrative Core (AC) has enhanced the collaborative research culture through the following endeavors: (i) Fostering interdisciplinary networks and team science, and collaborations between basic and clinical researchers; (ii) promoting education, training, mentorship and diversity, equity and inclusion (DEI); and (iii) supporting new investigators. The CU-DLDRC’ central research theme “Epithelial Cells and their Interactions in Digestive Homeostasis and Disease” encompasses two interrelated subthemes with major impact on digestive health: “Epithelial Homeostasis, Metabolism and Regeneration” (Subtheme 1) and “Epithelial Interactions in Inflammation and Preneoplasia” (Subtheme 2). Four Biomedical Cores provide access to cutting-edge technologies and facilities: Clinical Research and Biospecimen; Organoid and Cell Culture; Bioimaging; and Bioinformatics and Single Cell Analysis. The CU-DLDRC includes active Pilot and Feasibility (P/F) and Enrichment (EP) Programs, empowering the next generation of scientists and promoting education and intellectual exchange. The AC, as central component of the CU-DLDRC, will contribute to the collation and implementation of its mission, activities and success via optimal organization of the research base; fiscal management; coordination, evaluation and continuous evolution of its components; and communication with oversight committees, the NIDDK and other DDRCCs. The AC is directed by experienced leaders with complementary expertise: Robert Schwabe, MD, PhD (Director); Timothy Wang, MD and Kara Margolis, MD (Associate Directors), supported by AC administrator Seetha Srinivasan, PhD. The AC will promote the mission and success of the CU-DLDRC through these Specific Aims: To provide governance through efficient administration, budgetary oversight, scientific leadership and interactions with oversight committees (Aim 1). To ensure state-of-the-art services, efficient operation and cross-core collaboration by the Biomedical Cores (Aim 2). To promote the next generation of scientists and monitor their success via the P/F Program (Aim 3). To foster a fertile environment and intellectual exchange through seminars and retreats, and to promote DEI via the EP (Aim 4). To highlight the CU-DLDRC, its cores, educational activities and accomplishments on our website (Aim 5). Successful realization of these Aims will contribute to the effectiveness and success of the CU-DLDRC.
总结 哥伦比亚大学消化与疾病研究中心(CU-DLDRC)于2019年成立, 在过去的15年里,通过基础,转化和临床的蓬勃发展, research. CU-DLDRC反映了其成员的热情,合作,生产力和成功, 以及哥伦比亚大学对消化系统疾病研究的长期机构支持。CU-DLDRC 由49个富有成效的成员(30个正式成员和19个准成员)组成的互动小组, 在成人和儿童消化系统疾病研究和护理方面的卓越表现。自CU-DLDRC成立以来, 行政核心(AC)通过以下努力加强了合作研究文化:(i) 促进跨学科网络和团队科学,以及基础和临床之间的合作 研究人员;(ii)促进教育、培训、导师制和多样性、公平和包容(DEI);(iii) 支持新的调查员。CU-DLDRC的中心研究主题是“上皮细胞及其相互作用, 消化稳态和疾病”包括两个相互关联的子主题,对消化系统有重大影响。 健康:“上皮细胞稳态、代谢和再生”(副主题1)和“ 炎症和癌前病变”(副主题2)。四个生物医学核心为您提供 技术和设施:临床研究和生物标本;类器官和细胞培养;生物成像;以及 生物信息学和单细胞分析。CU-DLDRC包括主动试点和可行性(P/F), 丰富(EP)计划,赋予下一代科学家权力,促进教育和 智力交流。作为CU-DLDRC的核心组成部分,AC将有助于整理和 通过研究基地的最佳组织实施其使命、活动和成功;财政 管理;其组成部分的协调、评价和持续发展;以及与 监督委员会、NIDDK和其他DDRCC。AC由经验丰富的领导者领导, 补充专业知识:Robert施瓦贝,MD,PhD(主任); Timothy Wang,MD和Kara Margolis,MD (副董事),由AC管理员Seetha Srinivasan博士支持。AC将促进使命 CU-DLDRC通过这些具体目标取得的成功:通过有效的 行政管理、预算监督、科学领导以及与监督委员会的互动(目标1)。到 确保生物医学中心(Aim)提供最先进的服务、高效的运营和跨中心协作 2)。通过P/F计划(目标3)促进下一代科学家并监测他们的成功。促进 通过研讨会和务虚会提供丰富的环境和知识交流,并通过欧洲议会促进DEI (Aim 4)。在我们的网站上突出CU-DLDRC,其核心,教育活动和成就(Aim 5)。成功实现这些目标将有助于CU-DLDRC的有效性和成功。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert F. Schwabe其他文献

CD40 activates NFKB and JNK and enhances IL-8 secretion on human hepatic myofibroblasts
  • DOI:
    10.1016/s0016-5085(00)86204-6
  • 发表时间:
    2000-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert F. Schwabe;Bernd Schnabl;David A. Brenner
  • 通讯作者:
    David A. Brenner
OS-041-YI - X-box binding protein 1 (XBP1) in hepatic stellate cells (HSC) mitigates liver fibrosis
  • DOI:
    10.1016/s0168-8278(23)00497-x
  • 发表时间:
    2023-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hanghang Wu;Hui Ye;Juan Francisco Vilchez-Gómez;Marcos Fernandez Fondevila;Aveline Filliol;Robert F. Schwabe;Javier Vaquero;Rafael Bañares;Ruben Nogueiras;Eduardo Martínez-Naves;Scott Friedman;Yulia Nevzorova;Francisco Javier Cubero
  • 通讯作者:
    Francisco Javier Cubero
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
肝星状细胞通过 R-spondin 3 控制肝脏分区、大小和功能
  • DOI:
    10.1038/s41586-025-08677-w
  • 发表时间:
    2025-03-12
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Atsushi Sugimoto;Yoshinobu Saito;Guanxiong Wang;Qiuyan Sun;Chuan Yin;Ki Hong Lee;Yana Geng;Presha Rajbhandari;Celine Hernandez;Marcella Steffani;Jingran Qie;Thomas Savage;Dhruv M. Goyal;Kevin C. Ray;Taruna V. Neelakantan;Deqi Yin;Johannes Melms;Brandon M. Lehrich;Tyler M. Yasaka;Silvia Liu;Michael Oertel;Tian Lan;Adrien Guillot;Moritz Peiseler;Aveline Filliol;Hiroaki Kanzaki;Naoto Fujiwara;Samhita Ravi;Benjamin Izar;Mario Brosch;Jochen Hampe;Helen Remotti;Josepmaria Argemi;Zhaoli Sun;Timothy J. Kendall;Yujin Hoshida;Frank Tacke;Jonathan A. Fallowfield;Storm K. Blockley-Powell;Rebecca A. Haeusler;Jonathan B. Steinman;Utpal B. Pajvani;Satdarshan P. Monga;Ramon Bataller;Mojgan Masoodi;Nicholas Arpaia;Youngmin A. Lee;Brent R. Stockwell;Hellmut G. Augustin;Robert F. Schwabe
  • 通讯作者:
    Robert F. Schwabe
Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease
肝星状细胞:在健康和疾病中平衡稳态、肝保护和纤维化
Modulation of soluble CD40 ligand bioactivity with anti-CD40 antibodies.
用抗 CD40 抗体调节可溶性 CD40 配体生物活性。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Robert F. Schwabe;S. Hess;Judith P. Johnson;Hartmut Engelmann
  • 通讯作者:
    Hartmut Engelmann

Robert F. Schwabe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert F. Schwabe', 18)}}的其他基金

The Columbia University Digestive and Liver Disease Research Center
哥伦比亚大学消化和肝脏疾病研究中心
  • 批准号:
    10612948
  • 财政年份:
    2022
  • 资助金额:
    $ 24.62万
  • 项目类别:
The Columbia University Digestive and Liver Disease Research Center
哥伦比亚大学消化和肝脏疾病研究中心
  • 批准号:
    10443133
  • 财政年份:
    2022
  • 资助金额:
    $ 24.62万
  • 项目类别:
The Administrative Core
行政核心
  • 批准号:
    10443134
  • 财政年份:
    2022
  • 资助金额:
    $ 24.62万
  • 项目类别:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
肝星状细胞亚群在 NASH-HCC 中的促肿瘤和抑肿瘤作用
  • 批准号:
    10278434
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
Protective and fibrosis-independent functions of hepatic stellate cells
肝星状细胞的保护性和纤维化独立功能
  • 批准号:
    10597076
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
Protective and fibrosis-independent functions of hepatic stellate cells
肝星状细胞的保护性和纤维化独立功能
  • 批准号:
    10378664
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
肝星状细胞亚群在 NASH-HCC 中的促肿瘤和抑肿瘤作用
  • 批准号:
    10454375
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
肝星状细胞亚群在 NASH-HCC 中的促肿瘤和抑肿瘤作用
  • 批准号:
    10654714
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
DAMP 及其受体将肝细胞死亡与 HSC 激活和肝纤维化联系起来
  • 批准号:
    10224799
  • 财政年份:
    2019
  • 资助金额:
    $ 24.62万
  • 项目类别:
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
DAMP 及其受体将肝细胞死亡与 HSC 激活和肝纤维化联系起来
  • 批准号:
    9917105
  • 财政年份:
    2019
  • 资助金额:
    $ 24.62万
  • 项目类别:

相似海外基金

EAGER: Toward a Decentralized Cross-administrator Zone Management System: Policy and Technology
EAGER:走向去中心化的跨管理员区域管理系统:政策和技术
  • 批准号:
    2331936
  • 财政年份:
    2023
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Standard Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
  • 批准号:
    2043230
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Continuing Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
  • 批准号:
    2043334
  • 财政年份:
    2021
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Continuing Grant
Making of the base for patient safety management skill of visiting nurse administrator by the web conference system
利用网络会议系统构建出诊护士管理者患者安全管理技能基础
  • 批准号:
    19K10768
  • 财政年份:
    2019
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the nursing administrator training program to improve leadership behavior focused on emotional intelligence
制定护理管理人员培训计划,以改善以情商为重点的领导行为
  • 批准号:
    18K17464
  • 财政年份:
    2018
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Automated Network Management that Dynamically Reflects Administrator Intent
动态反映管理员意图的自动化网络管理
  • 批准号:
    18K18038
  • 财政年份:
    2018
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Administrator support perceived as useful for professional growth by novice psychiatric home-visit nursing staff
新手精神科家访护理人员认为管理员支持对专业成长有用
  • 批准号:
    17H07005
  • 财政年份:
    2017
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The Facts and Problems on Management of Public Museums: Validation of Designated Administrator System
公共博物馆管理的事实与问题:指定管理员制度的验证
  • 批准号:
    17K01212
  • 财政年份:
    2017
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on Transformation of the School Administrator Preparation and Evaluation System in the United States
美国学校管理人员培养与评价体系转型研究
  • 批准号:
    26780449
  • 财政年份:
    2014
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The Family Court's Supervision of Property Administrator
家庭法院对财产管理人的监督
  • 批准号:
    26380108
  • 财政年份:
    2014
  • 资助金额:
    $ 24.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了